Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

Nature Genetics volume 37, pages 486–494 (2005)Cite this article

Abstract

Antigen presentation to T cells by MHC molecules is essential for adaptive immune responses. To determine the exact position of a gene affecting expression of MHC molecules, we finely mapped a previously defined rat quantitative trait locus regulating MHC class II on microglia in an advanced intercross line. We identified a small interval including the gene MHC class II transactivator (Mhc2ta) and, using a map over six inbred strains combined with gene sequencing and expression analysis, two conserved Mhc2ta haplotypes segregating with MHC class II levels. In humans, a –168A → G polymorphism in the type III promoter of the MHC class II transactivator (MHC2TA) was associated with increased susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction, as well as lower expression of MHC2TA after stimulation of leukocytes with interferon-γ. We conclude that polymorphisms in Mhc2ta and MHC2TA result in differential MHC molecule expression and are associated with susceptibility to common complex diseases with inflammatory components.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Fine mapping of the Vra4 locus in the AIL F8 generation.
Figure 2: VRA-induced expression of MHC class II molecules in the spinal cord.
Figure 3: Haplotype map over Vra4 in rat strains examined for expression of MHC class II molecules.
Figure 4: RT-PCR analysis of Mhc2ta and Cd74 transcript levels in ipsilateral L3 segments from F8 rats 14 d after VRA stratified for marker D10Mgh25.
Figure 5: Expression of MHC class II molecules in the striatum after intracerebral injections of IFN-γ or LPS.
Figure 6: Effect of −168A → G polymorphism on class II associated transcript levels.
Figure 7: Correlation between MHC2TA and MHC class II associated transcripts in human PBMCs stimulated with 50 U ml−1 recombinant IFN-γ (rIFNγ).

Similar content being viewed by others

References

  1. Flügel, A. et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14, 547–560 (2001).

    Article  Google Scholar 

  2. Sedgwick, J.D., Schwender, S., Gregersen, R., Dorries, R. & ter Meulen, V. Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J. Exp. Med 177, 1145–1152 (1993).

    Article  CAS  Google Scholar 

  3. Piehl, F. et al. Non-MHC gene regulation of nerve root injury-induced spinal cord inflammation and neuron death. J. Neuroimmunol. 101, 87–97 (1999).

    Article  CAS  Google Scholar 

  4. Lundberg, C., Lidman, O., Holmdahl, R., Olsson, T. & Piehl, F. Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains. J. Comp. Neurol. 431, 75–87 (2001).

    Article  CAS  Google Scholar 

  5. Ting, J.P. & Trowsdale, J. Genetic control of MHC class II expression. Cell 109, 21–33 (2002).

    Article  Google Scholar 

  6. Boss, J.M. & Jensen, P.E. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15, 105–111 (2003).

    Article  CAS  Google Scholar 

  7. Dahlman, I. et al. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J. Immunol. 162, 2581–2588 (1999).

    CAS  PubMed  Google Scholar 

  8. Lidman, O. et al. Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS. J. Neurosci. 23, 9817–9823 (2003).

    Article  CAS  Google Scholar 

  9. Maehlen, J., Schroder, H., Klareskog, L., Olsson, T. & Kristensson, K. Axotomy induces MHC class I antigen expression on rat nerve cells. Neurosci. Lett. 92, 8–13 (1988).

    Article  CAS  Google Scholar 

  10. Streit, W.J., Graeber, M.B. & Kreutzberg, G.W. Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J. Neuroimmunol. 21, 117–123 (1989).

    Article  CAS  Google Scholar 

  11. Darvasi, A. & Soller, M. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141, 1199–1207 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Jagodic, M. et al. An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J. Immunol. 173, 1366–1373 (2004).

    Article  CAS  Google Scholar 

  13. Libby, P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002).

    Article  CAS  Google Scholar 

  14. Patarroyo, J.C. et al. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immun. 3, 34–37 (2002).

    Article  CAS  Google Scholar 

  15. Steimle, V., Otten, L.A., Zufferey, M. & Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135–146 (1993).

    Article  CAS  Google Scholar 

  16. Chang, C.H., Guerder, S., Hong, S.C., van Ewijk, W. & Flavell, R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4, 167–178 (1996).

    Article  CAS  Google Scholar 

  17. Chang, C.H. & Flavell, R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181, 765–767 (1995).

    Article  CAS  Google Scholar 

  18. Kern, I., Steimle, V., Siegrist, C.A. & Mach, B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7, 1295–1299 (1995).

    Article  CAS  Google Scholar 

  19. Nagarajan, U.M., Bushey, A. & Boss, J.M. Modulation of gene expression by the MHC class II transactivator. J. Immunol. 169, 5078–5088 (2002).

    Article  Google Scholar 

  20. Muhlethaler-Mottet, A., Otten, L.A., Steimle, V. & Mach, B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16, 2851–2860 (1997).

    Article  CAS  Google Scholar 

  21. Otten, L.A., Steimle, V., Bontron, S. & Mach, B. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28, 473–478 (1998).

    Article  CAS  Google Scholar 

  22. Stüve, O. et al. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J. Immunol. 169, 6720–6732 (2002).

    Article  Google Scholar 

  23. Tompkins, S.M. et al. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168, 4173–4183 (2002).

    Article  CAS  Google Scholar 

  24. Baumgart, M., Moos, V., Schuhbauer, D. & Muller, B. Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. Proc. Natl. Acad. Sci. USA 95, 6936–6940 (1998).

    Article  CAS  Google Scholar 

  25. Otten, L.A. et al. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J. Immunol. 170, 1150–1157 (2003).

    Article  CAS  Google Scholar 

  26. Hegde, N.R., Chevalier, M.S. & Johnson, D.C. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 24, 278–285 (2003).

    Article  CAS  Google Scholar 

  27. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–511 (2003).

    Article  CAS  Google Scholar 

  28. Sartoris, S. et al. Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum. Immunol. 61, 599–604 (2000).

    Article  CAS  Google Scholar 

  29. Janitz, M., Reiners-Schramm, L., Muhlethaler-Mottet, A., Rosowski, M. & Lauster, R. Analysis of the sequence polymorphism within class II transactivator gene promoters. Exp. Clin. Immunogenet. 18, 199–205 (2001).

    Article  CAS  Google Scholar 

  30. Rasmussen, H.B., Kelly, M.A. & Clausen, J. Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene. Hum. Immunol. 62, 371–377 (2001).

    Article  CAS  Google Scholar 

  31. Hammarberg, H. et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20, 5283–5291 (2000).

    Article  CAS  Google Scholar 

  32. Olsson, T., Lidman, O. & Piehl, F. Harm or heal - divergent effects of autoimmune neuroinflammation? Trends Immunol. 24, 5–6 (2003).

    Article  CAS  Google Scholar 

  33. Cao, D. et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33, 215–223 (2003).

    Article  CAS  Google Scholar 

  34. Mallat, Z. et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108, 1232–1237 (2003).

    Article  CAS  Google Scholar 

  35. Turesson, C., Jarenros, A. & Jacobsson, L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann. Rheum. Dis. 63, 952–955 (2004).

    Article  CAS  Google Scholar 

  36. Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6, 1399–1402 (2000).

    Article  CAS  Google Scholar 

  37. Youssef, S. et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78–84 (2002).

    Article  CAS  Google Scholar 

  38. Padyukov, L.C.S., Stolt, P., Alfredsson, L. & Klareskog, L. The EIRA study group. A gene-environment interaction between smoking and shared epitope genes in HLA-DRB1 provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50, 3085–3092 (2004).

    Article  CAS  Google Scholar 

  39. Khademi, M. et al. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J. Immunol. 172, 7169–7176 (2004).

    Article  CAS  Google Scholar 

  40. Lander, E.S. et al. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1, 174–181 (1987).

    Article  CAS  Google Scholar 

  41. Lander, E.S. & Botstein, D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121, 185–199 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Schneider, S., Roessli, D. & Excoffier, L. Arlequin ver. 2000: A Software for Population Genetics Data Analysis (Genetics and Biometrics Laboratory, University of Geneva, Switzerland, 2000).

    Google Scholar 

  43. Stephens, M. & Donnelly, P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73, 1162–1169 (2003).

    Article  CAS  Google Scholar 

  44. McDonald, W.I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121–127 (2001).

    Article  CAS  Google Scholar 

  45. Arnett, F.C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315–324 (1988).

    Article  CAS  Google Scholar 

  46. Stolt, P. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 62, 835–841 (2003).

    Article  CAS  Google Scholar 

  47. Eriksson, P. et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 24, 551–557 (2004).

    Article  CAS  Google Scholar 

  48. Jobs, M., Howell, W.M., Strömqvist, L., Mayr, T. & Brookes, A.J. DASH-2 flexible, low-cost, and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays. Genome Res. 13, 916–924 (2003).

    Article  CAS  Google Scholar 

  49. Jurinke, C., van den Boom, D., Cantor, C.R. & Koster, H. Automated genotyping using the DNA MassArray technology. Methods Mol. Biol. 187, 179–192 (2002).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

L.P., P.E. and E.Å. contributed equally to the human genetic part of the study. We thank K. Becanovic, J. Lorentzen, L. Bäckdahl and E. Wallström for expert advice in genetics and practical help with breeding of the AIL; K. Duvefelt for collaboration on microarray analysis; and the EIRA group, E. Jemseby, the MI group and B. Burt for their contributions. This study was supported by grants from the Wadsworth Foundation, Torsten and Ragnar Söderbergs Foundation, The Swedish Heart-Lung Foundation, the Petrus and Augusta Hedlunds Foundation, Björklunds Foundation, Nils and Bibbi Jenssens Foundation, the Swedish Foundation for Neurologically Disabled, Montel Williams Foundation, Svenska Läkaresällskapet, Max and Edit Follins Foundation, the King Gustaf V and Queen Victoria foundation, AFA insurance and the Swedish Research Council, af Ugglas Foundation, Novartis Foundation, Royal Physiographic Society and The Swedish Medical Research Council.

Author information

Author notes

  1. Maria Swanberg, Olle Lidman, Fredrik Piehl and Tomas Olsson: These authors contributed equally to the work.

Authors and Affiliations

  1. Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Stockholm, Sweden

    Maria Swanberg, Olle Lidman, Maja Jagodic, Anna Lobell, Mohsen Khademi, Fredrik Piehl & Tomas Olsson

  2. Department of Medicine, Rheumatology Unit, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden

    Leonid Padyukov, Ola Börjesson & Lars Klareskog

  3. Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden

    Per Eriksson & Anders Hamsten

  4. Department of Neurology, Neurotec, Karolinska Institutet, Huddinge, Sweden

    Eva Åkesson & Jan Hillert

  5. Department of Biosciences at Novum, Karolinska Institutet, Huddinge, Sweden

    Cecilia M Lindgren & Juha Kere

  6. Department of Medicine, Danderyd's Hospital, Stockholm, Sweden

    Pia Lundman

  7. Center for Genomics and Bioinformatics, Karolinska Institutet, Stockholm, Sweden

    Anthony J Brookes

  8. Department of Clinical Sciences, Lund University, Malmö, Sweden

    Holger Luthman

  9. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Lars Alfredsson

Authors
  1. Maria Swanberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olle Lidman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leonid Padyukov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Per Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eva Åkesson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maja Jagodic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anna Lobell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mohsen Khademi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ola Börjesson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Cecilia M Lindgren
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Pia Lundman
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Anthony J Brookes
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Juha Kere
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Holger Luthman
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Lars Alfredsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Jan Hillert
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Lars Klareskog
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Anders Hamsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Fredrik Piehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Tomas Olsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomas Olsson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Genotype and allele frequencies for SNP2 (rs2229320plus27bp) and SNP3 (rs4774). (PDF 57 kb)

Supplementary Table 2

Primers and probes used for RT-PCR. (XLS 20 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swanberg, M., Lidman, O., Padyukov, L. et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37, 486–494 (2005). https://doi.org/10.1038/ng1544

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1544

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing